Business · 14/06/2012Updated: 10/17/2026 · 1 min read
FDA Corrects Guidance on Irritable Bowel Syndrome Treatment
Summary
The Food and Drug Administration (FDA) has corrected a notice regarding the availability of a guidance document on clinical evaluation of drugs for treating irritable bowel syndrome, which was published with an incorrect docket number in the Federal Register on May 31, 2012.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →